Jeffrey Vietri

13PUBLICATIONS
38CO-AUTHORS
Infant and child healthPacific Peoples social determinants of healthEpidemiological modellingPanel data analysisHealth promotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 29, 2026
Practical Considerations Shaping Pneumococcal Vaccine Selection: A Multinational Cross-Sectional Survey of Healthcare Professionals.

|Aug 26, 2026
Residual Disparities in US Children Hospitalized Due to All-Cause Pneumonia Following Implementation of Childhood PCV13 in National Immunization Program.

|Jul 28, 2026
Socioeconomic value of adult respiratory vaccination in the United States: a benefit-cost analysis.

|Jul 16, 2026
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in the 20-Valent Pneumococcal Conjugate Vaccine in the Adult Population in France.

|Jan 21, 2026
Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.

Diana Mendes, Ahuva Averin, Mark Atwood

|Sep 25, 2025
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations.

Haeseon Lee, Jeong-Yeon Cho, Jeffrey Vietri

Pageof 3

Frequent Collaborators

2 joint publications

Diana Mendes

2 joint publications

Kazumasa Kamei

1 joint publications

Masayo Sato

1 joint publications

Jens Olsen